Compare Merck & Co., Inc. (MRK) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs First Trust Cloud Computing ETF — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while First Trust Cloud Computing ETF trades at $174.89 (market cap $3.47B). The key difference: Merck & Co., Inc. is far larger — about 101.2× First Trust Cloud Computing ETF's market cap, and Merck & Co., Inc. pays a 2.39% dividend while First Trust Cloud Computing ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and First Trust Cloud Computing ETF for 85 Days on average.
| MRK | SKYY | |
|---|---|---|
Market Cap | $351.28B | $3.47B |
Volume | 7,969,665 | 176,159 |
Sector | Health | — |
52-Week High | $156.43 | $171.01 |
52-Week Low | $82.49 | $104.16 |
Typical Hold Time | 98 Days | 85 Days |
Enterprise Value | $398.04B | — |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, down 0.28% on the day, with a bearish technical signal and key support at $140. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.14. Revenue grew to $65.01B in 2025, and net income reached $18.25B, though the P/E ratio is elevated at 113.9. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline.
The outlook for MRK is mixed, with solid fundamentals and analyst optimism countered by high valuation and bearish technicals. The consensus price target of $158.78 suggests upside potential, but investors face risks from competitive pressures and integration challenges from recent M&A activity. Earnings growth and pipeline developments remain key catalysts.
SKYY (First Trust Cloud Computing ETF) trades at $170.14, down 0.37% on the day but near its 52-week high of $169.41. Technical indicators show a bullish trend with strong moving average support and neutral oscillators. The ETF benefits from strong secular trends in cloud computing and AI adoption, with recent news highlighting institutional position adjustments and positive sector momentum.
The outlook remains positive given cloud computing's growth trajectory and AI infrastructure demand. Key risks include sector concentration and market volatility. Analyst sentiment is generally favorable, though valuation metrics are not provided in current data. The ETF's diversified exposure to cloud infrastructure positions it well for continued technology adoption trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
